$0.86
3M Ago | 1M Ago | Current | |
Buy | 0 | 0 | 4 |
Outperform | 0 | 0 | 2 |
Hold | 3 | 3 | 2 |
Underperform | 2 | 2 | 0 |
Sell | 1 | 1 | 0 |
The latest share price target for Chemomab Therapeutics Ltd (CMMB) is $5.67, offered by 8 analysts offering 12-month price forecasts.
Chemomab Therapeutics Ltd (CMMB) has a maximum of 5.59 upside potential, based on 8 analysts offering 12-month price forecasts.
Based on 8 analysts tracking and researching Chemomab Therapeutics Ltd (CMMB), 75% have a buy recommendation. Remaining 25% have either sell or hold recommendations.
The latest share price of Chemomab Therapeutics Ltd (CMMB) is $0.86 as of 22/05/2024.
6 of total 8 analysts offering stock ratings for Chemomab Therapeutics Ltd CMMB have recommended buy rating.